Filana Therapeutics (SAVA) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.63
-0.58
-0.52
-0.47

Details

Expected EPS
-0.59
Actual EPS
-0.63
Surprise EPS
-0.04
Surprise Percent
+6.78%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.63 per share for Q2 2023.

0 Comments

Share your thoughts